Kitea Health was honored to attend the 2024 Hydrocephalus Association Conference. Our team, Dr. Simon Malpas (CEO) and Natalia Lopez (COO), along with PhD candidate Sang Ho Kim, participated in the conference to deepen Kitea's understanding of the challenges faced by the hydrocephalus community.
A primary focus of for the attendance was to gather critical insights from patients and clinicians to inform our pivotal clinical trial. By connecting directly with those impacted by hydrocephalus, we aimed to ensure our research aligns with their priorities and needs. The conference also provided a valuable platform to collaborate with industry partners, accelerating our collective efforts to develop innovative treatments for this complex condition.
We extend our sincere gratitude to the Hydrocephalus Association for organizing such an important event. This platform fosters connection, knowledge sharing, and progress within the hydrocephalus community, and we commend the Association’s dedication to improving the lives of those affected.
